Veterinary API Market Report - Vaccines, Anti-Infectives & Biological APIs Analysis | Top Companies SUANFARMA, Alivira Animal Health Limited & Zoetis.

Market Size and Growth
The global Veterinary API Market was valued at US$ 6.84 billion in 2023 and is projected to reach US$ 12.29 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.6% during the forecast period 2024-2031.

Market Overview

Veterinary Active Pharmaceutical Ingredients (APIs) are critical components in medications designed for animal health, delivering therapeutic effects to treat, prevent, or manage diseases in animals. Derived from chemical synthesis, biotechnological processes, or natural substance extraction, veterinary APIs are essential for producing high-quality pharmaceuticals, including vaccines, anti-infectives, and antiparasitics. The market serves companion and production animals through various administration routes and service types, driven by rising pet ownership, increasing livestock populations, and advancements in veterinary healthcare. Challenges include high costs, stringent regulations, and synthesis complexities.

📌 Access valuable insights with our sample report - (Please enter your Corporate Email ID to get priority access):- https://www.datamintelligence.com/download-sample/veterinary-api-market?rk

Market Opportunities

Opportunities include expanding API production for emerging zoonotic diseases, leveraging biotechnological advancements for biological APIs, and increasing outsourcing to cost-effective regions like Asia-Pacific. Growing demand for pet insurance and innovative delivery systems also presents significant growth potential.

Key Trends

Rising adoption of vaccines for disease prevention in livestock and pets.
Increasing use of biological APIs for advanced therapies.
Growing trend of contract manufacturing and outsourcing to optimize costs.
Recent Developments

May 2024: EUROAPI signed a €130-150 million contract manufacturing agreement with a global animal health group to supply a critical veterinary product.

January 2024: Huateng Pharma launched a specialized veterinary API line, including Fluralaner and Sarolaner, targeting companion animals.

December 2023: Indian Immunologicals began constructing a Rs. 700 crore vaccine facility in Hyderabad to combat diseases like foot-and-mouth disease.

June 2023: Boehringer Ingelheim introduced a combined CircoFLEX-PRRS MLV vaccine for swine, enhancing disease management flexibility.

November 2022: SeQuent Scientific acquired Tineta Pharma, boosting its livestock formulations business in India.

Market Dynamics: Drivers

Increasing Animal Population and Pet Ownership
The rising global animal population and pet ownership significantly drive market growth. In India, the pet dog population reached 33 million in 2023 and is projected to hit 51 million by 2028, increasing demand for advanced veterinary API drugs. Globally, growing pet ownership, with over 90.5 million U.S. households owning pets (NAPHIA), fuels demand for high-quality veterinary care, including surgical procedures and medications. Innovations like eVerse.AI's CowGPT (December 2023) and Lasa Supergenerics' Oxyclozanide (June 2021) further support market expansion by addressing livestock and companion animal health needs.

Market Dynamics: Restraints
High Costs and Regulatory Challenges
High animal care costs, complex synthesis of large molecular weight APIs, and stringent regulatory requirements hinder market growth. Limited approved therapies and increasing veterinary research costs further challenge manufacturers, particularly in meeting global safety and efficacy standards.

📌 Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/veterinary-api-market

Market Segment Analysis

By API Type: Vaccines Dominate
The vaccines segment held a 56.5% market share in 2024, driven by the rising prevalence of animal diseases like foot-and-mouth disease and rabies, necessitating effective immunization. Developments like Indian Immunologicals' Rs. 700 crore vaccine facility (December 2023) and Boehringer Ingelheim's CircoFLEX-PRRS MLV vaccine (June 2023) underscore the segment's growth.

By Synthesis Type
Chemical-based APIs lead due to precise control over production, but biological APIs are growing rapidly due to biotechnological advancements.

By Route of Administration
Injectable APIs dominate for their efficacy, followed by oral and topical routes, with injectables favored for vaccines and anti-infectives.

By Animal Type
Production animals hold a significant share due to rising livestock demand, while companion animals are growing due to increasing pet ownership.

By Service Type
In-house manufacturing leads, but contract outsourcing is the fastest-growing segment, driven by cost efficiencies in regions like India and China.

By Region
North America dominates, while Asia-Pacific is the fastest-growing region due to cost advantages and rising animal health awareness.

Geographical Share

North America Holds Significant Share
North America accounted for a significant market share in 2024, driven by advanced veterinary infrastructure, high pet ownership (90.5 million U.S. households), and rising zoonotic disease prevalence. Strategic partnerships, like Dutch and Synchrony's pet insurance collaboration (November 2022), and innovations, such as Merck's vaccine facility in Boxmeer (January 2023), reinforce the region's dominance.

Asia-Pacific Grows Rapidly
Asia-Pacific is the fastest-growing region, fueled by increasing pet and livestock populations, cost-effective manufacturing, and government initiatives like India's National Animal Disease Control Program (September 2023). The region's large exporters and rising healthcare investments further drive growth.

📌 Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=veterinary-api-market

Major Players
Key companies in the veterinary API market include:
SUANFARMA
Alivira Animal Health Limited
Zoetis
Excel Industries
Sidhiv Pharma
Chempro Pharma Private Limited
De Ofichem Group
NGL Fine-Chem Ltd.
AMGIS Lifescience Ltd.
Rochem International Inc.

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.